Literature DB >> 18398330

Masked hypertension in obstructive sleep apnea syndrome.

Jean-Philippe Baguet1, Patrick Lévy, Gilles Barone-Rochette, Renaud Tamisier, Hélène Pierre, Marie Peeters, Jean-Michel Mallion, Jean-Louis Pépin.   

Abstract

BACKGROUND: Ambulatory blood pressure (BP) monitoring (ABPM) detects subjects with normal clinic but high ambulatory 24-h BP, that is, masked hypertension.
METHODS: One hundred and thirty newly diagnosed obstructive sleep apnea syndrome (OSAS) patients, free of recognized cardiovascular disease were included (111 men, age = 48 +/- 1 years, BMI = 27.6 +/- 0.4 kg/m, respiratory disturbance index (RDI = 42 +/- 2/h). Clinic BP, 24-h ABPM, baroreflex sensitivity (BRS), echocardiography and carotid intima-media thickness (IMT) were assessed.
RESULTS: Forty-one patients (31.5%) were normotensive, 39 (30.0%) exhibited masked hypertension, four (3.1%) white-coat hypertension and 46 (35.4%) hypertension. Significant differences were found between normotensive, masked hypertensive and hypertensive patients in terms of BRS (10.5 +/- 0.8, 8.0 +/- 0.6 and 7.4 +/- 0.4 ms/mmHg, respectively, P < 0.001), carotid IMT (624 +/- 17, 650 +/- 20 and 705 +/- 23 microm, respectively, P = 0.04) and left ventricular mass index (37 +/- 1, 40 +/- 2 and 43 +/- 1 g/height2.7, respectively, P = 0.003). A clinic systolic BP more than 125 and a diastolic BP more than 83 mmHg led to a relative risk (RR) of 2.7 and a 90% positive predictive value for having masked hypertension.
CONCLUSION: Masked hypertension is frequently underestimated in OSAS and is nearly always present when clinic BP is above 125/83 mmHg.

Entities:  

Mesh:

Year:  2008        PMID: 18398330     DOI: 10.1097/HJH.0b013e3282f55049

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  27 in total

1.  Sense and Sensitivity: Obstructive Sleep Apnea, Morning Blood Pressure, and Occult Hypertension.

Authors:  Richard J Castriotta
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

2.  Morning Diastolic Blood Pressure May Be Independently Associated With Severity of Obstructive Sleep Apnea in Non-Hypertensive Patients: A Cross-Sectional Study.

Authors:  Łukasz Mokros; Wojciech Kuczyński; Łukasz Franczak; Piotr Białasiewicz
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

Review 3.  How should we manage a patient with masked hypertension?

Authors:  Paolo Palatini
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-06

Review 4.  Obstructive sleep apnea and ambulatory blood pressure monitoring: current evidence and research gaps.

Authors:  Andrea Pio-Abreu; Heitor Moreno; Luciano F Drager
Journal:  J Hum Hypertens       Date:  2021-01-07       Impact factor: 3.012

Review 5.  Does treatment-resistant hypertension exist in children? A review of the evidence.

Authors:  Ian Macumber; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2019-05-30       Impact factor: 3.714

Review 6.  Resistant hypertension, obstructive sleep apnoea and aldosterone.

Authors:  T Dudenbostel; D A Calhoun
Journal:  J Hum Hypertens       Date:  2011-06-09       Impact factor: 3.012

7.  Metabolic risk factors and masked hypertension in the general population: the Finn-Home study.

Authors:  M-Ra Hänninen; T J Niiranen; P J Puukka; A M Jula
Journal:  J Hum Hypertens       Date:  2014-01-02       Impact factor: 3.012

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

Review 9.  Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.

Authors:  J Peacock; K M Diaz; A J Viera; J E Schwartz; D Shimbo
Journal:  J Hum Hypertens       Date:  2014-02-27       Impact factor: 3.012

Review 10.  Mechanisms of cardiac dysfunction in obstructive sleep apnea.

Authors:  Jean-Philippe Baguet; Gilles Barone-Rochette; Renaud Tamisier; Patrick Levy; Jean-Louis Pépin
Journal:  Nat Rev Cardiol       Date:  2012-09-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.